Make your money go further for just 25p per day

More than Money: Lidco

Like many British healthcare companies, Lidco (LON: LID) sees the US as the main geography for growth. But rather than gather up the dregs of the blood monitoring market, the company has hurled itself headlong into competition with its biggest competitor. Lidco's chief executive Matt Sassone thinks Lidco has the tools to emerge from the battle victorious, in our latest podcast, he explained to us why he's confident that the US can produce the growth that shareholders have long been waiting for.


Sign up for more great content

Register to continue reading this article.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

For access to the top news and insights from the investment world

REGISTER FREE TODAY

Become a Champion Investor for as little as £3.20 per report or get a year's worth of money-making analysis for just £90.

START FREE TRIAL

More on LiDCO Group plc

More than Money: Lidco

25/04/2019 · Podcasts

Like many British healthcare companies, Lidco (LON: LID) sees the US as the main geography for…


LiDCO Group plc (LID) – second profitable year for this exciting pharma company 

31/03/2015 · News & Insights
LiDCO supplies minimally invasive and non-invasive hemodynamic equipment to hospitals, to monitor the amount of blood…

More Podcasts

More than Money: Ocean Dial Asset Management

16/09/2019

Non-executive directors: a lesson in governance

Investor’s Champion podcast: Oh Burford!

08/08/2019 · Burford Capital Ltd